Polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) are not the same condition, though they share enough symptoms that even doctors sometimes struggle to tell them apart. Both cause joint pain, stiffness, and inflammation, but they differ in which parts of the body they target, how they’re diagnosed, how they respond to treatment, and how long they last. The overlap is real enough that more than 20% of people initially diagnosed with PMR are later rediagnosed with rheumatoid arthritis.
Where the Pain Shows Up
The most reliable way to distinguish these two conditions is by looking at which joints are involved. PMR causes pain and stiffness primarily in the shoulders and pelvic girdle, the large muscle groups around the hips. The discomfort is symmetrical, affecting both sides of the body, and it centers on the areas closest to the trunk.
Rheumatoid arthritis most commonly affects the hands, feet, and knees. It tends to target smaller joints, particularly the knuckles and the joints at the base of the fingers and toes. RA can also involve larger joints like the shoulders and hips, but when the small joints of the hands and feet are swollen and painful, that points strongly toward RA rather than PMR.
There is a complication, though. When RA develops in people over 60 (called elderly-onset RA), it can look a lot like PMR. This form tends to involve larger, more proximal joints like the knees and shoulders, comes on more suddenly, and is less likely to show the classic hand involvement. That overlap is what makes the two conditions so easy to confuse in older adults.
Who Gets Each Condition
PMR almost exclusively affects people over 50, with most cases diagnosed in those over 70. In the United States, roughly 53 out of every 100,000 people aged 50 and older develop it each year. It is slightly more common in women, and considerably more common in people of Northern European descent.
Rheumatoid arthritis can strike at any age, though it most often appears between 30 and 60. Women are affected about two to three times more often than men. When RA begins after age 60, the gender gap narrows and the disease tends to behave differently, which is part of why it can mimic PMR.
Morning Stiffness and Symptom Patterns
Both conditions cause morning stiffness lasting longer than 45 minutes. In PMR, this stiffness is concentrated in the shoulders and hips and can make it difficult to get out of bed, raise your arms overhead, or climb stairs. The stiffness and pain often come on quickly, sometimes developing over just a few days to two weeks.
RA stiffness is more diffuse and particularly noticeable in the hands. People with RA often describe difficulty making a fist or gripping objects first thing in the morning. Over time, RA can cause visible joint swelling and deformity, especially in the fingers. PMR generally does not cause this kind of joint damage.
Blood Tests and Diagnosis
One of the key tools for separating these conditions is blood work. RA often produces specific antibodies: rheumatoid factor (RF) and anti-CCP antibodies. When these markers are present, the diagnosis leans clearly toward RA. About 70 to 80% of RA patients test positive for at least one of these antibodies.
PMR does not produce these antibodies. Instead, the diagnosis relies on elevated inflammation markers (ESR and CRP), the characteristic pattern of shoulder and hip pain, age over 50, and a rapid response to corticosteroids. The 2012 classification criteria from the European League Against Rheumatism and the American College of Rheumatology require bilateral shoulder pain, morning stiffness over 45 minutes, elevated inflammation markers, and new hip pain as the core diagnostic features.
The diagnostic gray zone appears when RA is “seronegative,” meaning those telltale antibodies are absent. Seronegative RA in older adults can be genuinely difficult to distinguish from PMR based on blood tests alone. In these cases, doctors rely more heavily on imaging, the specific joints involved, and how the disease behaves over time.
What Imaging Reveals
Ultrasound and MRI help separate the two conditions by showing different patterns of inflammation. In PMR, the inflammation tends to occur outside the joint itself, particularly in the bursae (fluid-filled cushions around the joint). Subacromial-subdeltoid bursitis, an inflammation of the bursa near the top of the shoulder, is a hallmark finding. It shows up on ultrasound with about 80% sensitivity for PMR and is significantly more accurate for diagnosis than looking for inflammation inside the shoulder joint.
RA, by contrast, causes synovitis: inflammation of the joint lining itself. Over time, this can erode bone and cartilage, leading to permanent joint damage visible on X-rays. PMR typically does not cause bone erosion. When imaging shows erosive changes, the diagnosis shifts strongly toward RA regardless of other findings. MRI and PET scans in PMR patients sometimes reveal additional areas of inflammation along the spine and pelvis that wouldn’t be present in typical RA.
How They Respond to Treatment
Perhaps the most dramatic difference between PMR and RA is how they respond to low-dose corticosteroids like prednisone. PMR symptoms typically improve markedly within 24 to 48 hours of starting treatment. This rapid, near-complete relief is so characteristic that it’s sometimes used as a diagnostic tool. If someone with suspected PMR doesn’t improve quickly on corticosteroids, doctors reconsider the diagnosis.
RA does not respond this way. While corticosteroids can reduce RA inflammation, they don’t produce the same swift, dramatic relief. RA treatment usually requires disease-modifying medications that work over weeks to months to slow the immune system’s attack on the joints. The treatment goal in RA is to prevent long-term joint destruction, which requires ongoing medication for most people.
Disease Course and Long-Term Outlook
PMR is generally a self-limiting condition. Most people need corticosteroid treatment for one to three years, with doses gradually tapered down. Some people experience relapses when doses are reduced too quickly, but the condition eventually resolves for the majority. PMR does not typically cause permanent joint damage.
RA is a chronic, lifelong disease. Without treatment, it progressively destroys joint tissue and can lead to significant disability. Even with modern treatments, RA requires ongoing management. The seronegative, elderly-onset form that most closely mimics PMR tends to have a somewhat better prognosis, particularly when there are no bone erosions at diagnosis.
The PMR-to-RA Pipeline
The relationship between these conditions is more complex than a simple either/or. Research shows that over 20% of patients initially diagnosed with PMR eventually receive a rheumatoid arthritis diagnosis. This has led some researchers to suggest that PMR and elderly-onset RA may exist on a spectrum rather than being entirely separate diseases.
If you’ve been diagnosed with PMR and notice new symptoms in your hands, wrists, or feet, or if your symptoms stop responding well to low-dose corticosteroids, those are signals that the diagnosis may need revisiting. The development of small joint swelling in someone originally diagnosed with PMR is a particularly important red flag for underlying RA.
PMR and Giant Cell Arteritis
One risk unique to PMR is its association with giant cell arteritis, an inflammation of the blood vessels that supply the head and eyes. About 10% of people with PMR also develop giant cell arteritis, and roughly half of people with giant cell arteritis also have PMR. RA does not carry this same association.
The warning signs are new, severe headaches (usually in the temples), scalp tenderness, and jaw pain while chewing. Vision changes, including double vision or sudden loss of sight in one eye, are the most urgent symptom because untreated giant cell arteritis can cause permanent blindness. These symptoms require immediate medical attention.